Increased risk and related factors of depression among patients with COPD: a population-based cohort study
- PMID: 24138872
- PMCID: PMC4016549
- DOI: 10.1186/1471-2458-13-976
Increased risk and related factors of depression among patients with COPD: a population-based cohort study
Abstract
Background: Depression is a common and mostly undertreated problem in patients with chronic diseases. However, population-based studies on the association between chronic obstructive pulmonary disease (COPD) and subsequent depression are limited in Asian populations. This study evaluated the incidence and risk factors of depression for patients with COPD in Taiwan.
Methods: Using the claims data from the National Health Insurance of Taiwan, we identified 38,010 COPD patients newly diagnosed in 2000-2004 and 38,010 subjects without COPD frequency, matched by sex, age and index date. The incidence rate and hazard ratio for depression were estimated by the end of 2008.
Results: The incidence rate of depression was 1.88 folds higher in the COPD cohort than in the non-COPD cohort (12.2 versus 6.47 per 1,000 person-years, p < 0.0001). The depression risk was the greatest within the first year following COPD diagnosis and tended to decline with follow-up time. Among COPD patients, multivariate analysis showed that younger women and low-income patients were at higher risk of depression. Hospitalization and comorbidities such as hypertension, arthritis, cancer, and heart disease were also significant predictors for depression risk.
Conclusion: This population-based cohort study demonstrated a strong relationship between COPD and subsequent depression. These findings could assist healthcare providers to pinpoint individuals with a higher predisposition to having depression, which could then facilitate the provision of culturally appropriate rehabilitation within the first year after the diagnosis of COPD.
Similar articles
-
The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.Respir Med. 2024 Jul;228:107672. doi: 10.1016/j.rmed.2024.107672. Epub 2024 May 17. Respir Med. 2024. PMID: 38763446
-
Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.QJM. 2014 Jul;107(7):537-43. doi: 10.1093/qjmed/hcu027. Epub 2014 Feb 3. QJM. 2014. PMID: 24497528
-
Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study.BMJ Open. 2017 Jun 22;7(4):e014233. doi: 10.1136/bmjopen-2016-014233. BMJ Open. 2017. PMID: 28646083 Free PMC article.
-
A follow-up study on restless legs syndrome in chronic obstructive pulmonary disease population.Sleep Med. 2021 Apr;80:9-15. doi: 10.1016/j.sleep.2021.01.016. Epub 2021 Jan 15. Sleep Med. 2021. PMID: 33545488
-
Increased risk of chronic obstructive pulmonary disease among patients with Helicobacter pylori infection: a population-based cohort study.Clin Respir J. 2017 Sep;11(5):558-565. doi: 10.1111/crj.12382. Epub 2015 Oct 9. Clin Respir J. 2017. PMID: 26364850
Cited by
-
Defining COPD-Related Comorbidities, 2004-2014.Chronic Obstr Pulm Dis. 2014 May 6;1(1):51-63. doi: 10.15326/jcopdf.1.1.2014.0119. Chronic Obstr Pulm Dis. 2014. PMID: 28848811 Free PMC article. Review.
-
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.Int J Chron Obstruct Pulmon Dis. 2021 Mar 31;16:865-875. doi: 10.2147/COPD.S294053. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33833507 Free PMC article.
-
Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.J Psychosom Res. 2019 Mar;118:18-26. doi: 10.1016/j.jpsychores.2019.01.002. Epub 2019 Jan 7. J Psychosom Res. 2019. PMID: 30782350 Free PMC article.
-
Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study.Clinics (Sao Paulo). 2015 Feb;70(2):91-6. doi: 10.6061/clinics/2015(02)04. Clinics (Sao Paulo). 2015. PMID: 25789516 Free PMC article.
-
Impact of anxiety and depression on the prognosis of copd exacerbations.BMC Pulm Med. 2022 Apr 29;22(1):169. doi: 10.1186/s12890-022-01934-y. BMC Pulm Med. 2022. PMID: 35488330 Free PMC article.
References
-
- Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;13:993–1013. - PubMed
-
- World Health Organization. The global burden of disease: 2004 update. 2012. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat....
-
- Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;13:1498–1504. - PubMed
-
- Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R. et al.The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. medicare population. Respir Med. 2008;13:1248–1256. - PubMed
-
- Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD. 2006;13:211–218. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical